Viewing Study NCT01730833


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-01-08 @ 10:40 AM
Study NCT ID: NCT01730833
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-03
First Post: 2012-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
Sponsor: City of Hope Medical Center
Organization: